Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Zai Lab ADR | ZLAB | Sep 17, 2024 | 20.77 | +0.44 |
Zalatoris II Acquisition | ZLS | Sep 17, 2024 | 11.06 | 0.00 |
Zapata Computing | ZPTA | Sep 17, 2024 | 0.38 | -1.51 |
Zapp Electric Vehicles Group | ZAPP | Sep 17, 2024 | 3.14 | -1.88 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Sep 17, 2024 | 48.20 | -0.15 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Sep 17, 2024 | 67.11 | -0.11 |
Zebra Technologies A | ZBRA | Sep 17, 2024 | 354.52 | +3.12 |
Zedge B | ZDGE | Sep 17, 2024 | 3.25 | +3.17 |
ZEEKR Intelligent Technology Holding | ZK | Sep 17, 2024 | 16.12 | +2.35 |
Zentalis Pharmaceuticals | ZNTL | Sep 17, 2024 | 4.10 | +11.41 |
Zentek | ZTEK | Sep 17, 2024 | 0.77 | -1.90 |
Zenvia A | ZENV | Sep 17, 2024 | 1.49 | +5.67 |
Zeo Energy A | ZEO | Sep 17, 2024 | 1.26 | -20.75 |
Zepp Health ADR | ZEPP | Sep 17, 2024 | 3.31 | -2.93 |
Zeta Global A | ZETA | Sep 17, 2024 | 27.44 | +0.77 |
Zevia A | ZVIA | Sep 17, 2024 | 1.09 | +1.87 |
Zevra Therapeutics | ZVRA | Sep 17, 2024 | 7.53 | -3.21 |
Zhibao Technology | ZBAO | Sep 17, 2024 | 3.69 | -5.36 |
Zhihu A ADR | ZH | Sep 17, 2024 | 3.30 | +1.23 |
Zhongchao A | ZCMD | Sep 17, 2024 | 1.25 | -3.85 |
Ziff Davis | ZD | Sep 17, 2024 | 51.34 | +3.26 |
Zillow Group A | ZG | Sep 17, 2024 | 60.88 | +0.41 |
Zillow Group C Capital Stock | Z | Sep 17, 2024 | 62.81 | +0.35 |
ZIM | ZIM | Sep 17, 2024 | 19.70 | +6.31 |
Zimmer Biomet | ZBH | Sep 17, 2024 | 106.24 | -1.11 |
ZimVie | ZIMV | Sep 17, 2024 | 16.90 | +0.90 |
Zions Bank | ZION | Sep 17, 2024 | 46.92 | +0.36 |
Zions Bank A Pref | ZIONP | Sep 17, 2024 | 22.21 | +0.32 |
Zions Bank G Pref | ZIONO | Sep 17, 2024 | 26.08 | +0.85 |
ZipRecruiter A | ZIP | Sep 17, 2024 | 10.11 | +1.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.